Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy

被引：0
作者：
Honing, Judith [1 ]
Koch, Arjun D. [1 ]
Siersema, Peter D. [1 ]
Spaander, Manon [1 ,2 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Erasmus Univ, Erasmus MC Canc Inst, Med Ctr, Dr Molewaterpl 40,POB 2040, NL-3000 CA Rotterdam, Netherlands
来源：
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY | 2024年 / 68卷
关键词：
Salvage; Endoscopic; Submucosal dissection; Definitive; Chemoradiotherapy; SQUAMOUS-CELL CARCINOMA; LOCAL FAILURE; NEOADJUVANT CHEMORADIOTHERAPY; SUBMUCOSAL DISSECTION; MUCOSAL RESECTION; SALVAGE TREATMENT; RANDOMIZED-TRIAL; CANCER; RECURRENCE; SURGERY;
D O I：
10.1016/j.bpg.2024.101885
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Definitive chemoradiation is the recommended treatment for locally advanced, irresectable oesophageal cancer and a valid alternative to neoadjuvant chemoradiotherapy (CRT) with surgery in oesophageal squamous cell cancer (OSCC) patients. In case of locoregional recurrence, salvage treatment can be considered in fit and resectable patients. Salvage surgery is a valid option but associated with significant morbidity. Therefore, for tumors confined to the mucosa or submucosal layers endoscopic resection is a good and less -invasive alternative. Over the last decade several case -series have demonstrated a high technical success rate of endoscopic treatment after definitive CRT. In this review we summarize the clinical outcomes and challenges of endoscopic treatment of early recurrence after definitive CRT in oesophageal cancer.
引用
收藏
页数：6
相关论文
共 35 条
  • [1] Salvage endoscopic resection after definitive chemoradiotherapy for esophageal cancer: a Western experience
    Al-Kaabi, Ali
    Schoon, Erik J.
    Deprez, Pierre H.
    Seewald, Stefan
    Groth, Stefan
    Giovannini, Marc
    Braden, Barbara
    Berr, Frieder
    Lemmers, Arnaud
    Hoare, Jonathan
    Bhandari, Pradeep
    van der Post, Rachel S.
    Verhoeven, Rob H. A.
    Siersema, Peter D.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2021, 93 (04) : 888 - +
  • [2] Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118
  • [3] Waiting to Operate The Risk of Salvage Esophagectomy
    Boerner, Thomas
    Harrington, Caitlin
    Tan, Kay See
    Adusumilli, Prasad S.
    Bains, Manjit S.
    Bott, Matthew J.
    Downey, Robert J.
    Huang, James
    Ilson, David H.
    Isbell, James M.
    Janjigian, Yelena Y.
    Park, Bernard J.
    Rocco, Gaetano
    Rusch, Valerie W.
    Sihag, Smita
    Wu, Abraham J.
    Jones, David R.
    Molena, Daniela
    [J]. ANNALS OF SURGERY, 2023, 277 (05) : 781 - 788
  • [4] Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly
    Bostel, Tilman
    Akbaba, Sati
    Wollschlaeger, Daniel
    Mayer, Arnulf
    Nikolaidou, Eirini
    Murnik, Markus
    Kirste, Simon
    Ruehle, Alexander
    Grosu, Anca-Ligia
    Debus, Juergen
    Fottner, Christian
    Moehler, Markus
    Grimminger, Peter
    Schmidberger, Heinz
    Nicolay, Nils Henrik
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01)
    Cooper, JS
    Guo, MD
    Herskovic, A
    Macdonald, JS
    Martenson, JA
    Al-Sarraf, M
    Byhardt, R
    Russell, AH
    Beitler, JJ
    Spencer, S
    Asbell, SO
    Graham, MV
    Leichman, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1623 - 1627
  • [6] Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy plus /- cetuximab in oesophageal cancer
    Crosby, T.
    Hurt, C. N.
    Falk, S.
    Gollins, S.
    Staffurth, J.
    Ray, R.
    Bridgewater, J. A.
    Geh, J. I.
    Cunningham, D.
    Blazeby, J.
    Roy, R.
    Maughan, T.
    Griffiths, G.
    Mukherjee, S.
    [J]. BRITISH JOURNAL OF CANCER, 2017, 116 (06) : 709 - 716
  • [7] The Pattern of Residual Tumor After Neoadjuvant Chemotherapy for Locally Advanced Esophageal Cancer and Its Clinical Significance
    Hashimoto, Tadayoshi
    Makino, Tomoki
    Yamasaki, Makoto
    Tanaka, Koji
    Miyazaki, Yasuhiro
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Motoori, Masaaki
    Kimura, Yutaka
    Nakajima, Kiyokazu
    Morii, Eiichi
    Mori, Masaki
    Doki, Yuichiro
    [J]. ANNALS OF SURGERY, 2020, 271 (05) : 875 - 884
  • [8] EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer
    Hattori, S
    Muto, M
    Ohtsu, A
    Boku, N
    Manabe, T
    Doi, T
    Ishikura, S
    Yoshida, S
    [J]. GASTROINTESTINAL ENDOSCOPY, 2003, 58 (01) : 65 - 70
  • [9] Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?
    Hombu, Takuya
    Yano, Tomonori
    Hatogai, Ken
    Kojima, Takashi
    Kadota, Tomohiro
    Onozawa, Masakatsu
    Yoda, Yusuke
    Hori, Keisuke
    Oono, Yasuhiro
    Ikematsu, Hiroaki
    Fujii, Satoshi
    [J]. DIGESTIVE ENDOSCOPY, 2018, 30 (03) : 338 - 346
  • [10] Salvage endoscopic submucosal dissection for recurrent esophageal squamous-cell carcinoma after definitive chemoradiotherapy
    Ishii N.
    Suzuki K.
    Fujita Y.
    [J]. Clinical Journal of Gastroenterology, 2011, 4 (2) : 85 - 88
1234